Foster Dykema Cabot & Partners, LLC Novartis Ag Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 936 shares of NVS stock, worth $107,902. This represents 0.01% of its overall portfolio holdings.
Number of Shares
936
Previous 936
-0.0%
Holding current value
$107,902
Previous $94 Million
5.96%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.4 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$855 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$854 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$685 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $248B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...